Qubit Pharmaceuticals’ Post

Exploring Arbidol's Conformational Behavior in Supercritical Carbon Dioxide: Unveiling 'Opened' and 'Closed' Conformer Groups In a groundbreaking study, researchers Konstantin V. Belov, Alexey A. Dyshin, and Ilya A. Khodov have delved into the conformational intricacies of arbidol, a pharmaceutical compound renowned for its broad applications in antiviral and immunomodulatory therapies. The research, published in the journal Molecular Liquids, focuses on arbidol's behavior in a supercritical carbon dioxide solution, shedding light on the compound's various conformers. https://lnkd.in/dNuwmK43

On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dkdWMzY5 The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

Join us on September 26-28, 2023 at Merck Research Laboratories, Boston, MA. at the Applied Pharmaceutical Analysis 2023 In-Person Event. Shiny Rajan, PhD, Director of Tissue Engineering at Javelin Biotech, will be presenting a poster: “Development of a Novel Milli-fluidic Liver Tissue Platform for Mechanistic Pharmacokinetic (PK) and Drug-Drug Interaction (DDI) Studies”

On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dz9Z8nXf The speakers Celestine Chi(AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

We are pleased to announce a collaborative agreement with the Universitat de Barcelona to develop and demonstrate new or enhanced applications of #NMR at 1 GHz for the pharmaceutical industry, especially in biologics and new drug modalities. The University of Barcelona installed in 2022 the first Avance Evo 1 GHz NMR instrument in Europe and is part of the Spanish Singular Scientific and Technical Large Scale Facilities network. The collaboration includes the synthesis of model therapeutic oligonucleotides by Dr. Terraza’s group at the University of Barcelona. Other therapeutics of interest are monoclonal antibodies, RNA, oligonucleotides, and peptides. This responds to the need to improve product risk assurance and the encouragement by the regulatory authorities to use state-of-the-art technology, including NMR. Read more: https://lnkd.in/dHYDJVD6 Centres Científics i Tecnològics de la Universitat de Barcelona (CCiTUB) #CCiTUB #Bruker #Pharma #Biomedicine #NMRchat

On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dxJX5nwn The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dNsHSDYW The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/d7NxaUjd The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

We are pleased to announce a collaborative agreement with the Universitat de Barcelona to develop and demonstrate new or enhanced applications of #NMR at 1 GHz for the pharmaceutical industry, especially in biologics and new drug modalities. The University of Barcelona installed in 2022 the first Avance Evo 1 GHz NMR instrument in Europe and is part of the Spanish Singular Scientific and Technical Large Scale Facilities network. The collaboration includes the synthesis of model therapeutic oligonucleotides by Dr. Terraza’s group at the University of Barcelona. Other therapeutics of interest are monoclonal antibodies, RNA, oligonucleotides, and peptides. This responds to the need to improve product risk assurance and the encouragement by the regulatory authorities to use state-of-the-art technology, including NMR. Read more: https://lnkd.in/d_6zSrSu Centres Científics i Tecnològics de la Universitat de Barcelona (CCiTUB) #CCiTUB #Bruker #Pharma #Biomedicine #NMRchat